Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Microbiology|April 7, 2016
Bacteria in Cancer Therapy: Renaissance of an Old ConceptSebastian Felgner, Dino Kocijancic, Michael Frahm, et al.
Trends in Microbiology|September 12, 2016
Biomimetic Salmonella: A Next-Generation Therapeutic Vector?Sebastian Felgner, Dino Kocijancic, Vinay Pawar, et al.
Gut Microbes|March 5, 2016
Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapySebastian Felgner, Dino Kocijancic, Michael Frahm, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2018
Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing Pseudomonas aeruginosaMathias Müsken, Vinay Pawar, Timo Schwebs, et al.
Oncotarget|April 27, 2017
Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibilityDino Kocijancic, Sara Leschner, Sebastian Felgner, et al.
Mbio|April 16, 2015
Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapyMichael Frahm, Sebastian Felgner, Dino Kocijancic, et al.
Mbio|May 3, 2018
Regulation of Flagellum Biosynthesis in Response to Cell Envelope Stress in Salmonella enterica Serovar TyphimuriumImke Spöring, Sebastian Felgner, Matthias Preuße, et al.
Oncotarget|June 22, 2017
Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infectionDino Kocijancic, Sebastian Felgner, Tim Schauer, et al.
Plos One|August 13, 2015
Characterization of Novel Factors Involved in Swimming and Swarming Motility in Salmonella enterica Serovar TyphimuriumJulia Andrea Deditius, Sebastian Felgner, Imke Spöring, et al.
Oncoimmunology|January 9, 2018
Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapySebastian Felgner, Dino Kocijancic, Michael Frahm, et al.
Pageof 2